Company Intelligence
Paige
MedTwenty Company Score 79Digital Pathology · New York, United States · Founded 2018
Digital pathology company with FDA-cleared prostate cancer detection and an expanding European regulatory footprint.
Key facts
Employees260
RevenueNot disclosed
Valuation$710m
Last roundSeries C, September 2026
Funding history
| Date | Round | Amount | Lead investor |
|---|---|---|---|
| Sep 2026 | Series C | $75m | Bessemer Venture Partners |
Timeline
- 24 Sep 2026Raises $75m Series C.
Benchmarks, competitor comparison and export
Professional membership unlocks side-by-side competitor comparison, historical financial series and CSV export for this company.
Upgrade